KPC Pharmaceuticals,Inc. (SHA:600422)
China · Delayed Price · Currency is CNY 14.85
+0.21 (1.43%)
Aug 1, 2025, 3:00 PM CST
Revenue by Product
Fiscal year is January - December.
Fiscal Year | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2016 - 2018 |
|---|---|---|---|---|---|---|
Period Ending | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2016 - 2018 |
Wholesale and Retail of Medicines and Equipment | 3.32B | Log In | Log In | Log In | Log In | Upgrade |
Wholesale and Retail of Medicines and Equipment Growth | -7.40% | Log In | Log In | Log In | Log In | Upgrade |
Cardiovascular and Cerebrovascular Treatment Areas | 2.08B | Log In | Log In | Log In | Log In | Upgrade |
Cardiovascular and Cerebrovascular Treatment Areas Growth | 13.67% | Log In | Log In | Log In | Log In | Upgrade |
Digestive System | 535.45M | Log In | Log In | Log In | Log In | Upgrade |
Digestive System Growth | -6.36% | Log In | Log In | Log In | Log In | Upgrade |
Gynecology | 332.16M | Log In | Log In | Log In | Log In | Upgrade |
Gynecology Growth | 20.61% | Log In | Log In | Log In | Log In | Upgrade |
Orthopedics Series | 218.05M | Log In | Log In | Log In | Log In | Upgrade |
Orthopedics Series Growth | -7.34% | Log In | Log In | Log In | Log In | Upgrade |
Other Business | 163.27M | Log In | Log In | Log In | Log In | Upgrade |
Other Business Growth | -70.96% | Log In | Log In | Log In | Log In | Upgrade |
Anti-malaria | 91.34M | Log In | Log In | Log In | Log In | Upgrade |
Anti-malaria Growth | -18.03% | Log In | Log In | Log In | Log In | Upgrade |
Other | 962.49M | Log In | Log In | Log In | Log In | Upgrade |
Other Growth | 5.49% | Log In | Log In | Log In | Log In | Upgrade |
Commodity | - | Log In | Log In | Log In | Log In | Upgrade |
Commodity Growth | - | Log In | Log In | Log In | Log In | Upgrade |
Medical Services | - | Log In | Log In | Log In | Log In | Upgrade |
Medical Services Growth | - | Log In | Log In | Log In | Log In | Upgrade |
Anti-infection | - | Log In | Log In | Log In | Log In | Upgrade |
Anti-infection Growth | - | Log In | Log In | Log In | Log In | Upgrade |
Liver Qi Stagnation | - | Log In | Log In | Log In | Log In | Upgrade |
Liver Qi Stagnation Growth | - | Log In | Log In | Log In | Log In | Upgrade |
Health Food Production | - | Log In | Log In | Log In | Log In | Upgrade |
Revenue by Geography
Fiscal year is January - December.
Fiscal Year | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2016 - 2018 |
|---|---|---|---|---|---|---|
Period Ending | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2016 - 2018 |
China | 7.57B | Log In | Log In | Log In | Log In | Upgrade |
China Growth | 0.07% | Log In | Log In | Log In | Log In | Upgrade |
Abroad | 116.76M | Log In | Log In | Log In | Log In | Upgrade |
Abroad Growth | -22.39% | Log In | Log In | Log In | Log In | Upgrade |
Hong Kong | 9.51M | Log In | Log In | Log In | Log In | Upgrade |